Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GNOSPV-01 by Geneos Therapeutics for Hormone-Sensitive Prostate Cancer: Likelihood of Approval
GNOSPV-01 is under clinical development by Geneos Therapeutics and currently in Phase I for Hormone-Sensitive Prostate Cancer. According to GlobalData,...
GNOSPV-01 by Geneos Therapeutics for Glioblastoma Multiforme (GBM): Likelihood of Approval
GNOSPV-01 is under clinical development by Geneos Therapeutics and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
GNOSPV-01 by Geneos Therapeutics for Small-Cell Lung Cancer: Likelihood of Approval
GNOSPV-01 is under clinical development by Geneos Therapeutics and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...